Dr Harry Adelson ND DAAPM

Dr. Harry Adelson, a diplomate of the American Academy of Pain Management (AAPM), practices naturopathic pain medicine in Salt Lake City, Utah. He has presented on prolotherapy for the AAPM, The French Society of Mesotherapy, and the Chinese Association of Anesthesiology. He has authored a chapter on prolotherapy in the seventh edition of AAPM’s textbook, Pain Management, a Guide for Clinicians. He is the founding president of the Naturopathic Academy of Therapeutic Injection.

2007 - Regenerative Injection Therapy (RIT – also known as Prolotherapy) using Autologous Platelet Concentrate

We will explore the history, mechanisms of action, indications, data, protocols, case studies and view video demonstrations of RIT/prolotherapy with and without the use of autologous platelet concentrate. 

Educational Objectives

1. Understand the history and current use of RIT/prolotherapy
2. Understand the proposed mechanisms of action of RIT/prolotherapy
3. Get an overview of the data, hear case studies and see video demonstrations of RIT/prolotherapy
4. Receive an introduction to the use of autologous platelet concentrate with RIT/prolotherapy

The World Health Organization (WHO) and the United Nations have deemed 2001-2011 as the “bone and joint decade”. Worldwide, musculoskeletal conditions are the most common causes of severe long-term pain and physical disability. WHO has determined that by the year 2010 musculoskeletal pain will account for 25% of all healthcare expenditures in developing nations. Traditional pain management interventions, orthopedic surgeries, and many pharmacologic strategies, frequently carry significant risk and expense and are frequently ineffective. Regenerative injection therapy (also know as prolotherapy) is widely practiced in the USA as a treatment for musculoskeletal conditions. It is a safe and effective interventional pain technique involving the injection of local anesthetics and hypertonic, natural substances such as dextrose and glucosamine sulfate directly into the site of soft tissue musculoskeletal injury or degeneration. This is done with the goal of launching a healing cascade that actually regenerates connective tissue, restores function, and significantly reduces pain. As RIT/prolotherapy actually regenerates connective tissue, it can be considered curative and not merely palliative. A growing number of practioners are exploring the use of autologous platelet concentrate with RIT/prolotherapy.